New VP of Operations for Exco InTouch
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exco InTouch, burke
Healthcare data services firm Exco InTouch has appointed Laurence Burke as its vice president of Operations. Burke takes over 20 …
‘Compassionate’ use of hep C combo
February 24, 2014Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi
A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …
New head of Biosimilars for Merck KGaA
February 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge
Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …
GSK/Theravance lung drug bags CHMP approval
February 21, 2014Sales and Marketing CHMP, COPD, GSK, Theravance, anoro
The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …
Avillion appoints pharma veteran as chief executive
February 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allison Jeynes-Ellis, Avillion
Drug development firm Avillion has appointed Dr Allison Jeynes-Ellis to be its chief executive. By stepping into the role Jeynes-Ellis …
Skin cancer pill shows ‘significant’ response
February 20, 2014Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo
Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …
Police raid Novartis Tokyo office
February 20, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo
Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …
Apple files healthcare tech headphones
February 20, 2014Medical Communications, Sales and Marketing Apple, Samsung, iwatch, technology, wearable
A recently-published Apple patent has shed light on a new health-monitoring device that will be built into a pair of …
RSA appoints director of Information
February 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claes Zackrisson, rsa
Life sciences executive search and interim management firm RSA has appointed Claes Zackrisson as its first director of information. Zackrisson …
Servier signs leukaemia deal
February 19, 2014Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia
French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …
Boehringer in hot water over Pradaxa risks
February 19, 2014Sales and Marketing Boehringer, Pradaxa, Xarelto, dabigatran, lawsuit
Boehringer Ingelheim attempted to delay and revise the publication of important drug information surrounding its new anticoagulant Pradaxa. This is …
Vimizin shown green light
February 19, 2014Research and Development, Sales and Marketing BioMarin, FDA, congenital enzyme disorder, vimizin
Regulators have shown the green light to BioMarin Pharmaceutical’s Vimizim as a treatment for a rare enzyme deficiency which affects …
NHS England delays patient data roll-out
February 19, 2014Medical Communications, Sales and Marketing England, HSCIC, NHS, care data, care.data, data, patients
The giant NHS database that could allow pharma firms to buy into patient records will now not be launched until …
EMA hires Accenture IT head
February 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dina Tsiambaou, EMA, IT
The European Medicines Agency (EMA) has welcomed Dina Tsiambaou as the new head of its Information Technology department. Tsiambaou joins …
Forest sold to Actavis for $25 billion
February 18, 2014Sales and Marketing Actavis, CNS, Forest, acquisition, labs, merger, synergy
The rumours of a substantial deal for Forest have been proven true after Actavis announced this afternoon that it will …
Bayer ‘disappointed’ with FDA
February 18, 2014Sales and Marketing ACS, Bayer, Xarelto, blood, rivaroxaban
Bayer HealthCare has expressed its dismay after the Food and Drug Administration once again rejected further indications for the company’s …
FDA seeks more specialisation in agency structure
February 18, 2014Manufacturing and Production FDA, GMP, ORA, fdasia, hamburg, opq, ufi
An internal review of the US Food and Drug Administration has concluded that the agency needs to restructure its compliance …
GSK starts rare blood trial
February 18, 2014Research and Development, Sales and Marketing GSK, blood, mepolizumab
GlaxoSmithKline has begun a Phase III study to look at mepolizumab in a rare condition characterised by vasculitis – widespread …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
